期刊文献+

人类微小RNA196a在早期胃癌中异常表达的生物学意义 被引量:2

Differential Expression of Hsa-mi R-196a in Early Gastric Cancer and Its Biological Significance
原文传递
导出
摘要 目的明确人类微小RNA196a(hsa-mi R-196a)在早期胃癌中异常表达模式,探讨其异常表达在早期胃癌发生与发展过程中的生物学作用。方法收集作者医院57例临床标本的包括52例早期胃癌患者手术及全血标本和5例非癌患者全血标本,以混合的正常人全血标本为对照,采用实时定量聚合酶链反应(polymerase chain reaction,PCR)检测hsa-mi R-196a在早期胃癌患者中的表达水平。利用生物信息学数据库预测hsa-mi R-196a调控的靶基因及信号通路。结果在52例早期胃癌标本中,44例(44/52,84.6%)手术标本高表达hsa-mi R-196a;42例(42/52,80.8%)全血标本高表达hsa-mi R-196a。利用生物信息学方法获得了211个可能受hsa-mi R-196a所调控的靶基因,这些靶基因参与了多条肿瘤相关信号通路。结论人类微小RNA196a在早期胃癌中高表达,这一表达模式可能通调控多条肿瘤相关信号通路参与胃癌的早期进展。 Objective To detect the differential expression pattern of hsa-mi R-196 a in early gastric cancer(GC),and discuss the molecular machenisms of its role in the process of early GC.Methods A total of 57 cases were selected,including52 surgical samples and matched blood samples from early GC patients,and 5 blood samples as control from non-cancer patients.Real-time polymerase chain reaction(PCR) was used to detecte the relative expression level of hsa-mi R-196 a.Meanwhile,bioinformatics databases were used to predict the target genes and correspondent signaling pathways regulated by hsa-mi R-196 a.Results Hsa-mi R-196 a was up-regulated in 44 of 52(84.6%) surgical samples,and 42 of 52(80.8%) blood samples in early GC.A total of 211 target genes were predicted for further study.These genes regulated by hsa-mi R-196 a participated in some of the cancer related pathways.Conclusion Hsa-mi R-196 a is up-regulated in early GC.This overexpressed pattern of hsa-mi R-196 a may play a role in the process of early GC by regulating multipy cancer related signaling pathways.
出处 《华南国防医学杂志》 CAS 2015年第5期343-345,359,共4页 Military Medical Journal of South China
关键词 早期胃癌 人类微小RNA196a 靶基因 信号通路 Early gastric cancer Hsa-mi R-196a Target genes Pathway
  • 相关文献

参考文献15

  • 1黄重发,付启梅,周怿,朱清.PRNCR1基因沉默对于胃癌细胞BGC-823增殖活性的影响[J].解放军医药杂志,2014,26(10):47-50. 被引量:1
  • 2徐航,邓家齐,吕沐瀚.siRNA干扰人端粒酶逆转录酶对胃癌细胞体外增殖转移的抑制作用[J].华南国防医学杂志,2013,27(10):699-702. 被引量:1
  • 3徐维田,郑国荣,熊毅敏,王艳,程翌,严志.早期胃癌微小RNA表达谱的建立[J].华南国防医学杂志,2013,27(7):464-467. 被引量:2
  • 4陈万青,张思维,郑荣寿,雷正龙,李光琳,邹小农,赵平.中国肿瘤登记地区2007年肿瘤发病和死亡分析[J].中国肿瘤,2011,20(3):162-169. 被引量:329
  • 5Kenneth J. Livak,Thomas D. Schmittgen.Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 ?ΔΔ C T Method[J]. Methods . 2001 (4)
  • 6Kamangar F,Dores GM,Anderson WF.Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. Journal of Clinical Oncology . 2006
  • 7Lim L P,Lau N C,Garrett-Engele P,et al.Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature . 2005
  • 8Lu J,Getz G,Miska EA,et al.MicroRNA expression profiles classify human cancers. Nature . 2005
  • 9Chen Caifu,Ridzon Dana A,Broomer Adam J,Zhou Zhaohui,Lee Danny H,Nguyen Julie T,Barbisin Maura,Xu Nan Lan,Mahuvakar Vikram R,Andersen Mark R,Lao Kai Qin,Livak Kenneth J,Guegler Karl J.Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Research . 2005
  • 10Manel Esteller.Non-coding RNAs in human disease. Nature Reviews Genetics . 2011

二级参考文献29

  • 1Wei-Jun Cao,Hai-Lu Wu,Bang-Shun He,Yu-Shu Zhang,Zhen-Yu Zhang.Analysis of long non-coding RNA expression profiles in gastric cancer[J].World Journal of Gastroenterology,2013,19(23):3658-3664. 被引量:33
  • 2Bray F, Parkin DM, Evaluation of data quality in the cancer registry: Principles and methods. Part I : Comparability, validity and timeliness [J]. Eur J Cancer, 2009, 45(5): 747-755.
  • 3Curado MP, Edwards B, Shin HR et al. Cancer incidence in five conti- nents, Vol. IX. IARC scientific publications No. 160[M]. Lyon: IARC, 2007.
  • 4Parkin DM, Chen VW, Ferlay J, et al. Comparability and quality control in cancer registration. IAtlC technical report No.19[M]. Lyon: IARC. 1994.
  • 5Felay J, Burkhard C, Whelan S, et al. Check and conversion programs for cancer registries. IARC technical report No.42[M]. Lyon: IARC, 2005.
  • 6Felay J. The IARCcrgTools program [CP/OL]. http://www.iaer.com.fr/iarc- crgtools.htm, 2006.
  • 7全国肿瘤登记中心.中国肿瘤登记工作指导手册[M].北京:中国协和医科大学出版社,2004.48-50.
  • 8Harley CB, Telomerase and cancer therapeutics[J]. Nat Rev Canc er,2008,8(3):167 -179.
  • 9Shay JW,Wright WE. Role of telomeres and telomerase in cancer[J]. Semin Cancer giol,2011,21 (6):349-353.
  • 10Yu ST,Li C,Lti MH,et al. Noninvasive and real time monitoring of the therapeutic response of tumors in vivo with an optimized hTERT promoter[J].Cancer, 2012,118 (7) ; 1884 1893.

共引文献348

同被引文献26

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部